Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank71
3Y CAGR-64.4%
Studio
Year-over-Year Change

Year-over-year debt growth rate

3Y CAGR
-64.4%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20247.22%
20232949.45%
2022-60.98%
2021160.31%
20200.00%
20190.00%
2018-100.00%
20170.00%